David Gillen
Tracked across 3 events · 32 articles · First seen May 05, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: David Gillen>>>, founder of Blueacre Technology>>>, will continue to lead the Dundalk operation and join the AP Technologies>>> leadership team after the acquisition.
May 19, 2026 · 6 articles
Regulatory
Hundreds of patients in the United States have filed personal injury lawsuits against Novo Nordisk and Eli Lilly and Company, alleging that widely used GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity caused a…
Impact: David Gillen is a plaintiff suing Novo Nordisk, alleging he lost vision after taking Ozempic; his case is one of the prominent individual claims.
Sep 21, 2026 · 20 articles
Business
Impact: Dr. David Gillen, Chief Medical Officer at Norgine, highlighted the clinical importance of the approved preventive option.
May 05, 2026 · 6 articles
ERGEN INTELLIGENCE
Track David Gillen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard